Fertility

 

Two Southeast Asian groups up for sale and an Indian group to IPO

In contrast to Europe, South and Southeast Asia are continuing to see significant deal activity. HBI hears that SAFE Fertility Group, one of Thailand’s largest IVF providers, and Qualitas Medical Group, a primary care chain with practices across Malaysia, Singapore and Australia, are up for sale. On top of this, Agilus Diagnostics, one of India’s largest labs groups, is set to IPO.
August 10, 2023

Fresenius half-year results get lukewarm reception

Investors had a mixed reaction to Fresenius’ half-year results, which saw the firm perform poorly on a group-level, but the core businesses highlighted by the restructuring plan perform well. The company did not confirm rumours of divestments.
August 4, 2023

Are fertility add-ons a bad idea?

In a successful fertility market, add-ons remain a controversial subject. HBI speaks to two experts with differing opinions to find out why.
July 28, 2023

Eugin sale “imminent”

Germany-based healthcare conglomerate Fresenius’ restructuring plans seem to be gathering steam, as HBI hears the sale of its Spain-based fertility clinic Eugin is imminent. 
July 14, 2023

HBI 2023: Opportunities for integrated women’s healthcare

“There are so many other areas in women’s health, beyond fertility, where funding isn’t developed”. Katya Zubareva, a partner at L.E.K. Consulting kicked off HBI 2023’s “Investment opportunity in fertility and women’s health” panel with a fascinating question: why is women’s health hyper focused on fertility?
July 12, 2023

HBI 2023: Healthcare regulation – opportunities and risks

Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.
July 7, 2023

Interview: Dr Marta Jansa Perez, Bridge Clinic

Demand for fertility is rising, but access can still be difficult. HBI speaks to Dr Marta Jansa Perez, director of embryology at low-cost UK fertility provider Bridge Clinic, to find out what can be done.
June 30, 2023

17 things we learned at HBI 2023: Our key insights and takeaways

Our annual conference took place earlier this week in London. Over a jam-packed three days of HBI 2023, an impressive array of delegates from across Europe and beyond gathered in the heart of London and shared their insights into the myriad challenges and abundant opportunities the sector faces, and offered their views on how some of them might be addressed. Here are some of our key takeaways.
June 23, 2023
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us